Zack Bloom Associate Corporate Zack advises life sciences and technology companies on a broad range of corporate and transactional matters. Before joining Fenwick, Zack was an associate at a prominent international law firm in Boston.
Publications SEC Division of Corporation Finance Announces Streamlined Rule 14a-8 Process for 2025–2026 Proxy Season November 17, 2025
Experience Fenwick Represents Day One in $285 Million Acquisition of Mersana Therapeutics November 13, 2025